Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Modelling the impact of COVID-19 in Australia to inform transmission reducing measures and health system preparedness

R Moss, J Wood, D Brown, F Shearer, AJ Black, AC Cheng, JM McCaw, View ORCID ProfileJ McVernon
doi: https://doi.org/10.1101/2020.04.07.20056184
R Moss
1Modelling and Simulation Unit, Melbourne School of Population and Global Health, The University of Melbourne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Wood
2School of Public Health and Community Medicine, UNSW Sydney
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D Brown
3Victorian Infectious Diseases Laboratory Epidemiology Unit at The Peter Doherty Institute for Infection and Immunity; The University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F Shearer
1Modelling and Simulation Unit, Melbourne School of Population and Global Health, The University of Melbourne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AJ Black
4School of Mathematical Sciences, University of Adelaide
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AC Cheng
5Infection Prevention and Healthcare Epidemiology Unit, Alfred Health; School of Public Health and Preventive Medicine, Monash University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JM McCaw
1Modelling and Simulation Unit, Melbourne School of Population and Global Health, The University of Melbourne
3Victorian Infectious Diseases Laboratory Epidemiology Unit at The Peter Doherty Institute for Infection and Immunity; The University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia
6School of Mathematics and Statistics, The University of Melbourne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J McVernon
1Modelling and Simulation Unit, Melbourne School of Population and Global Health, The University of Melbourne
3Victorian Infectious Diseases Laboratory Epidemiology Unit at The Peter Doherty Institute for Infection and Immunity; The University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia
7Infection and Immunity Theme, Murdoch Children’s Research Institute, the Royal Children’s Hospital, Melbourne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J McVernon
  • For correspondence: j.mcvernon@unimelb.edu.au
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background The ability of global health systems to cope with increasing numbers of COVID-19 cases is of major concern. In readiness for this challenge, Australia has drawn on clinical pathway models developed over many years in preparation for influenza pandemics. These models have been used to estimate health care requirements for COVID-19 patients, in the context of broader public health measures.

Methods An age and risk stratified transmission model of COVID-19 infection was used to simulate an unmitigated epidemic with parameter ranges reflecting uncertainty in current estimates of transmissibility and severity. Overlaid public health measures included case isolation and quarantine of contacts, and broadly applied social distancing. Clinical presentations and patient flows through the Australian health care system were simulated, including expansion of available intensive care capacity and alternative clinical assessment pathways.

Findings An unmitigated COVID-19 epidemic would dramatically exceed the capacity of the Australian health system, over a prolonged period. Case isolation and contact quarantine alone will be insufficient to constrain case presentations within a feasible level of expansion of health sector capacity. Overlaid social restrictions will need to be applied at some level over the course of the epidemic to ensure that systems do not become overwhelmed, and that essential health sector functions, including care of COVID-19 patients, can be maintained. Attention to the full pathway of clinical care is needed to ensure access to critical care.

Interpretation Reducing COVID-19 morbidity and mortality will rely on a combination of measures to strengthen and extend public health and clinical capacity, along with reduction of overall infection transmission in the community. Ongoing attention to maintaining and strengthening the capacity of health care systems and workers to manage cases is needed.

Funding Australian Government Department of Health Office of Health Protection, Australian Government National Health and Medical Research Council

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was directly funded by the Australian Government Department of Health. Robert Moss is supported by two National Health and Medical Research Council (NHMRC) Centres of Research Excellence: •The Australian Partnership for Preparedness Research on Infectious Disease Emergencies (APPRISE) GNT1116530. •Supporting Participatory Evidence use for the Control of Transmissible Diseases in our Region Using Modelling (SPECTRUM) GNT1170960. Jodie McVernon is supported by a NHMRC Principal Research Fellowship GNT1117140.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Not applicable - modelling study

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted April 11, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Modelling the impact of COVID-19 in Australia to inform transmission reducing measures and health system preparedness
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Modelling the impact of COVID-19 in Australia to inform transmission reducing measures and health system preparedness
R Moss, J Wood, D Brown, F Shearer, AJ Black, AC Cheng, JM McCaw, J McVernon
medRxiv 2020.04.07.20056184; doi: https://doi.org/10.1101/2020.04.07.20056184
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Modelling the impact of COVID-19 in Australia to inform transmission reducing measures and health system preparedness
R Moss, J Wood, D Brown, F Shearer, AJ Black, AC Cheng, JM McCaw, J McVernon
medRxiv 2020.04.07.20056184; doi: https://doi.org/10.1101/2020.04.07.20056184

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1093)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
  • Epidemiology (9758)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2304)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1554)
  • Health Policy (732)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (501)
  • Infectious Diseases (except HIV/AIDS) (11634)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2140)
  • Nursing (134)
  • Nutrition (335)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1172)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2173)
  • Public and Global Health (4648)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (455)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)